Nosocomial Bloodstream Infections in Finnish Hospitals during
|
|
- Justina Cooper
- 5 years ago
- Views:
Transcription
1 MAJOR ARTICLE Nosocomial Bloodstream Infections in Finnish Hospitals during O. Lyytikäinen, 1 J. Lumio, 3 H. Sarkkinen, 4 E. Kolho, 2 A. Kostiala, 5 P. Ruutu, 1 and the Hospital Infection Surveillance Team a 1 Department of Infectious Disease Epidemiology, National Public Health Institute, and 2 Helsinki University Central Hospital, Helsinki, 3 Tampere University Hospital, Tampere, 4 Päijät-Häme Central Hospital, Lahti, and 5 Jorvi Hospital, Espoo, Finland Prospective laboratory-based surveillance in 4 Finnish hospitals during identified 1477 cases of nosocomial bloodstream infection (BSI), with an overall rate of 0.8 BSIs per 1000 patient-days. Of BSI cases, 33% were in patients with a hematological malignancy and 15% were in patients with a solid malignancy; 26% were in patients who had undergone surgery preceding infection. Twenty-six percent of BSIs were related to intensive care, and 61% occurred in patients with a central venous catheter. Sixty-five percent of the 1621 causative organisms were gram positive, 31% were gram negative, and 4% were fungi. The most common pathogens were coagulase-negative staphylococci (31%), Escherichia coli (11%), Staphylococcus aureus (11%), and enterococci (6%). Methicillin resistance was detected in 1% of S. aureus isolates and vancomycin resistance in 1% of enterococci. The 7-day case-fatality ratio was 9% and was highest for infections caused by Candida (21%) and enterococci (18%). The overall rate of nosocomial BSIs was similar to rates in England and the United States, but S. aureus, enterococci, and fungi were less common in our study, and the prevalence of antibiotic resistance was lower. Nosocomial bloodstream infections (BSIs) are a major cause of morbidity and mortality throughout the world. Approximately 8% of all nosocomial infections reported in the United States are primary BSIs; these prolong patient hospitalization, are associated with increased mortality, and are costly for the health care system [1 5]. The incidence of nosocomial BSIs is increasing, as is the prevalence of antibiotic resistance among pathogens causing these infections [6 11]. Surveillance for nosocomial BSIs is the cornerstone Received 13 November 2001; revised 19 February 2002; electronically published 18 June Financial support: National Public Health Institute; Ministry of Social Affairs and Health (support was provided for the pilot phase of the project). a Members of the Hospital Infection Surveillance Team are listed at the end of the text. Reprints or correspondence: Dr. Outi Lyytikäinen, Finnish Hospital Infection Program, Dept. of Infectious Disease Epidemiology, Mannerheimintie 166, Helsinki, Finland (outi.lyytikainen@ktl.fi). Clinical Infectious Diseases 2002; 35:e by the Infectious Diseases Society of America. All rights reserved /2002/ E1$15.00 of prevention and control [12 15]. Local surveillance data are the basis for planning interventions in hospitals. The main objective of national hospital infection programs is to promote surveillance by providing a uniform approach to surveillance among participating hospitals and to offer country-specific data on nosocomial infections [16]. Nationally aggregated data also make international comparison possible. Levels of antibiotic resistance vary across Europe [11, 17]. Few systematically collected surveillance data on nosocomial infections and their causative agents from the Nordic countries and countries in which the prevalence of antimicrobial-resistant organisms is relatively low have been published. The Finnish Hospital Infection Program was started at the end of Two surveillance modules have now been developed, including hospital-wide surveillance for nosocomial BSIs. In the present article, we report the first results, which consist of the combined data from the 4 hospitals that participated in the program for surveillance for nosocomial BSIs during e14 CID 2002:35 (15 July) Lyytikäinen et al.
2 METHODS Hospitals and patients. Four Finnish hospitals volunteered to participate in the surveillance project during : 2 tertiary care hospitals (both with 1600 beds), 1 central hospital (with 600 beds), and 1 district hospital (with 450 beds). Surveillance was active, prospective, and hospital-wide, covering all patients admitted to departments offering acute care. The instructions to the participating hospitals generally advise that blood samples should be obtained for culture if the temperature of a patient is 138 C and/or a patient has other symptoms or signs that are compatible with BSI (e.g., hypothermia or hypotonia). No routine surveillance cultures were performed on samples from asymptomatic patients. Microbiologic methods. Each participating hospital laboratory detected growth in blood cultures, identified organisms, and performed susceptibility testing according to the modified National Committee for Clinical Laboratory Standards methods standardized by the Finnish Study Group for Antibiotic Resistance. Case finding and definitions. Local infection-control nurses in each hospital regularly reviewed the laboratory database for positive blood culture results. The Centers for Disease Control and Prevention definition for nosocomial BSI was used, and only laboratory-confirmed BSIs were included in the study [18]. Primary BSI referred to bacteremia or fungemia for which there was no documented focal source, including infections that resulted from intravenous or arterial catheter infections. Secondary BSI was defined as an infection that developed as a consequence of a documented infection with the same microorganism at another body site. Polymicrobial BSI referred to infections in which 11 microorganism was recovered from the blood within a 48-h period. Of the underlying conditions and possible risk factors, type of delivery, whether the patient was a newborn, whether Table 1. Nosocomial bloodstream infection (BSI) rates and proportion of BSIs related to intensive care, by specialty, in 4 Finnish hospitals during Specialty No. of BSIs a hematological or solid malignancy was present, and whether the patient had undergone organ transplantation or hemodialysis were recorded, as was the presence or absence of a central venous catheter. All patients who entered the operating room were recorded as having had surgery. Only patients who were hospitalized for at least 24 h in the intensive care unit (ICU) before the occurrence of BSI were considered to have received intensive care. All BSIs that became evident during the ICU stay or within 48 h after discharge from the ICU were considered to be related to intensive care. Clinical information and microbiological data were recorded by the local infection-control nurses on a standardized caserecord form sent monthly to the National Public Health Institute and entered into a common database. The outcome at 7 and 28 days from the date of the first positive blood culture result for a particular patient was obtained from the national population registry by use of unique person identifiers. Patientdays and discharges, by local codes and national specialty codes, were obtained from the information technology department of each hospital. Statistical analysis. Data were analyzed with Epi Info software (Centers for Disease Control and Prevention). Both antibiotic-resistant and intermediately susceptible organisms were considered to be resistant when resistance percentages were calculated. Univariate analysis of categorical variables was done with the x 2 test, using Yates s correction, or Fisher s exact test, as appropriate. Continuous variables were analyzed by Student s t test or by the Mann-Whitney U test, depending on the sample distribution. Feedback. Feedback was given through the project Web site, which was only accessible by use of a password given to authorized persons from the participating hospitals. Each hospital had access to its own data, and all hospitals had access to the aggregated data. Feedback included several report tables No. (%) of intensive care related BSIs BSIs/1000 patient-days Internal medicine (10) 1.6 Pediatrics (41) 1.3 Oncology General surgery (46) 0.6 Neurology (53) 0.4 Neurosurgery (84) 0.3 Pulmonology 31 7 (23) 0.3 Gynecology and obstetrics 29 1 (3) 0.1 Oral surgery 1 1 (100) 0.1 Dermatology 1 1 (100) 0.03 Total (26) 0.8 Nosocomial Bloodstream Infections in Finland CID 2002:35 (15 July) e15
3 Table 2. Underlying conditions and risk factors for nosocomial bloodstream infection (BSI) for patients with 1477 BSIs that were reported during Underlying condition or risk factor No. (%) of BSIs Central venous catheter 703 (61) a Hematological malignancy 484 (33) Surgery 374 (26) Stay in the intensive care unit 382 (26) Solid malignancy 212 (15) Newborn status 164 (11) Hemodialysis 107 (7) Organ transplantation 41 (3) Admission for obstetric care 17 (2) a BSI cases for which data on underlying conditions or risk factors were not available were excluded from the calculation. generated online from the database according to the users search criteria (hospital, time period, and ward/specialty). RESULTS A total of 1477 BSIs confirmed by positive results of blood culture were identified in 1265 patients. The overall infection rate was 0.8 infections per 1000 patient-days (range, ) and 2.7 infections per 1000 discharges (range, ). During the same period of time, 92,299 blood samples were obtained for culture (range, cultures per 1000 patient-days), and 16 BSIs were confirmed per 1000 blood cultures (range, 8 18). The rate of BSIs was highest among patients given care in internal medicine, pediatrics, oncology, and general surgery (table 1). The proportion of infections related to intensive care was highest among surgical, neurological, and pediatric patients. Most (77%) of the infections became evident during the hospital treatment period in which they were acquired; 23% were related to a preceding treatment period. Of the infections, 1229 (83%) were primary BSIs and 248 (17%) were secondary BSIs. The urinary tract was the most common source of secondary BSIs (84 [34%] of 248 BSIs). The mean age of the patients with BSI was 46 years (range,!1 100 years), and 865 (59%) were male. One-third of the infections occurred in patients who had a hematological malignancy (table 2). One-quarter of the infections occurred in surgical patients (26%) and in intensive care patients (26%). Information about the presence or absence of a central venous catheter within a 48-h period before the onset of the infection was available for 1152 infections (78%), and a catheter was present for 703 (61%) of those 1152 infections. A total of 1621 isolates were recovered from samples obtained during 1477 BSI episodes. Polymicrobial infections accounted for 9% (126) of the episodes. Sixty-five percent (1054) of causative organisms were gram positive, 31% (505) were gram negative, and 4% (62) were fungi. Of the bacteria, 55 (4%) were anaerobes. The most common pathogens were coagulase-negative staphylococci (CoNS), Escherichia coli, Staphylococcus aureus, and enterococci (table 3). Most CoNS (77%) were Staphylococcus epidermidis. Of enterococci, 59 (58%) were Enterococcus faecalis, and 40 (40%) were Enterococcus faecium. After E. coli, the most common gram-negative rods were Klebsiella and Pseudomonas species. Of the 62 Candida isolates, 23 were species other than Candida albicans (8 isolates were Candida parapsilosis, 4wereCandida glabrata, 2wereCandida tropicalis, and 9 were nonspeciated Candida strains). The estimate for the proportion of non-albicans Candida species varies from 23% to 37%, depending on whether the 9 nonspeciated Candida isolates are included. CoNS were the most common pathogens in all patient groups, except in obstetric patients, among whom S. aureus was equally common. Group B streptococci were common among newborns (17% of the microorganisms causing BSI among newborns vs. 1% among other patients; P!.01), and viridans streptococci were common among patients with hematological malignancy (11% among patients with hematological malignancy vs. 3% among other patients; P!.01). Candida species were more likely to cause BSIs in newborns (10% among newborns vs. 3% among other patients; P!.01) and patients in the ICU (10% among patients in the ICU vs. 2% among other patients; P!.01). Among patients with hematological malignancies, S. aureus (5% of isolates) and Candida species (2% of isolates) were rare. Resistance to methicillin was detected in 1% of S. aureus and 76% of CoNS isolates (table 4). Among enterococci, the proportion of vancomycin-resistant isolates was 1%. Among viridans streptococci, the proportion of penicillin-resistant isolates was 24%. Approximately one-third of Pseudomonas aeruginosa Table 3. Most common pathogens among 1621 isolates from patients with nosocomial bloodstream infections (BSIs) and casefatality ratios at 7 and 28 days from the date of the first positive blood culture result for a particular patient. Pathogen group No. (%) of isolates Case-fatality ratio (%) At day 7 At day 28 CoNS 501 (31) 6 13 Escherichia coli 182 (11) 9 14 Staphylococcus aureus 171 (11) 8 16 Enterococci 101 (6) Klebsiella species 83 (5) Viridans streptococci 82 (5) 8 9 Pseudomonas aeruginosa 81 (5) Candida species 62 (4) Enterobacter species 54 (3) Group B streptococci 45 (3) 3 5 NOTE. CoNS, coagulase-negative staphylococci. e16 CID 2002:35 (15 July) Lyytikäinen et al.
4 Table 4. Rates of antibiotic resistance among the most common gram-positive bacteria and gram-negative rods causing bloodstream infections in 4 Finnish hospitals during Percentage of resistant isolates (no. of resistant isolates/ no. tested) among gram-positive bacteria Antibiotic CoNS Staphylococcus aureus Enterococci Viridans streptococci Ampicillin 39 (38/98) 7 (3/46) Penicillin 24 (19/79) Erythromycin 63 (312/494) 10 (17/170) 31 (25/80) Imipenem/meropenem 42 (39/93) 0 (0/50) Clindamycin 53 (261/492) 4 (7/170) 6 (5/77) Oxacillin/methicillin 76 (363/480) 1 (2/163) Ciprofloxacin 32 (19/59) 17 (6/35) Gentamicin 7 (1/15) Tobramycin 63 (202/320) 3 (3/97) Vancomycin 0 (0/487) 0 (0/167) 1 (1/97) 0 (0/82) Percentage of resistant isolates (no. of resistant isolates/ no. tested) among gram-negative rods Escherichia coli Klebsiella species Pseudomonas aeruginosa Enterobacter species Ampicillin 44 (77/177) 99 (80/81) 100 (53/53) Piperacillin/tazobactam 1 (2/169) 3 (2/76) 30 (24/79) 25 (13/52) Imipenem/meropenem 0 (0/167) 0 (0/77) 12 (9/78) 2 (1/48) Cefotaxime 2 (4/176) 1 (1/75) 39 (20/51) Ceftazidime 2 (3/175) 0 (0/78) 11 (9/79) 31 (16/51) Cefuroxime 6 (10/176) 11 (9/80) 61 (31/51) Ciprofloxacin 5 (6/122) 6 (3/50) 38 (30/80) 0 (0/37) Tobramycin 1 (2/160) 0 (0/67) 30 (24/80) 2 (1/42) Amikacin 4 (3/67) NOTE. CoNS, coagulase-negative staphylococci. isolates were resistant to piperacillin/tazobactam, one-third to ciprofloxacin, one-third to tobramycin, 12% to imipenem, and 11% to ceftazidime. When the resistance to ceftazidime was used as a marker for the potential presence of extended-spectrum b-lactamases, 2% of E. coli and 0% of Klebsiella isolates were potential carriers of these enzymes. Information about outcome was available for 97% of patients. Among those patients, 123 (9%) died within 1 week after the onset of BSI, and 232 (16%) died within 1 month. The casefatality ratios were highest for infections caused by Candida and those caused by enterococci (table 3). The patients who died were significantly older (61 vs. 45 years; P!.01) and were more likely to have had a solid malignancy (32% vs. 13%; P!.01) or to have been admitted to the ICU (40% vs. 24%; P!.01). DISCUSSION Our surveillance focused on a single type of nosocomial infection with serious consequences: BSI [1 5]. In addition to being associated with significant morbidity and mortality, nosocomial BSIs are an important marker of antibiotic resistance among organisms that cause nosocomial infections. Hospital-wide surveillance data on BSIs have been collected in England, where 61 hospitals participated in a surveillance program during [19]. The overall BSI rate was similar to that in Finland; the mean rate in England was 0.6 infections per 1000 patient-days, compared with infections per 1000 days, the rate observed in our study. In earlier reports from the United States, the rates were also similar; in 1989, the primary BSI rate varied in nonteaching hospitals from 1.3 to 2.5 infections per 1000 discharges and in teaching hospitals from 3.8 to 6.5 infections per 1000 discharges, compared with infections per 1000 discharges in our study [7]. In our study, BSIs caused by methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE) constituted only 1% of the S. aureus and enterococcal isolates, even though 2 of the largest tertiary care hospitals in Finland were involved. In England, almost one-half of S. aureus isolates from Nosocomial Bloodstream Infections in Finland CID 2002:35 (15 July) e17
5 BSIs were resistant to methicillin, and 10% of enterococcal isolates were resistant to vancomycin [19]. Furthermore, in the United States, the proportion of MRSA among S. aureus causing BSI was 29%, and the proportion of VRE among enterococci was 18% [20]. However, the prevalence of antibiotic resistance among CoNS, viridans streptococci, and Pseudomonas species in Finland was similar to or higher than that reported in the United States and England [19, 20]. The methods used for susceptibility testing by the microbiology laboratories involved in our study were standardized, as part of a separate project carried out by the Finnish Study Group for Antibiotic Resistance, before our surveillance began. More than one-half of the causative microorganisms in our study were gram positive; this finding is similar to published results from the surveillance network of 49 US hospitals (Surveillance and Control of Pathogens of Epidemiologic Importance; SCOPE) during [20]. S. aureus, enterococci, and Candida species were less common in our study than in the Unites States, but the proportions of CoNS and polymicrobial infections were similar [20]. Our maximum estimate for the proportion of nosocomial BSIs caused by Candida species other than C. albicans was smaller than that for the US hospitals (37% vs. 47%, respectively) [20]. Unique person identifiers allowed us to retrieve comprehensive data on the outcomes of infections from the national population registry. Almost one-tenth of patients with nosocomial BSIs died within 1 week of the first positive blood culture result, and 16% died within 1 month. The case-fatality ratios were highest for infections caused by Candida species (42%) and enterococci (31%). In the US SCOPE network, the 1-month case-fatality ratio varied by microorganism, from 21% to 40%, and, in a teaching hospital in Iowa during the 1980s and 1990s, from 17% to 35% [20, 21]. Comparison of site-specific infection rates between different hospitals is not recommended [16]. However, our feedback on the surveillance results to participating hospitals raised great interest, because no uniformly collected data on overall rates, rates by specialty, distribution of causative agents, and antibiotic-resistance patterns among causative agents for different patient groups had previously been available. The participating hospitals have had an opportunity to analyze their own data by time, place, and patient group, as well as to compare these data with the results of the aggregated data. This enables the hospitals to identify problem areas in which interventions and/ or intensified surveillance are needed. The national hospital infection programs in many European countries and in the United States include in their surveillance, in addition to surgical-site infections, only infections in ICUs [16]. Resources can be saved by focusing the surveillance on high-risk units and procedures. Focusing also allows more exhaustive collection of data on device use for improved risk adjustment and more-reliable estimations of the effect of control interventions. On the basis of our results, the surveillance of blood culture confirmed nosocomial BSIs and control measures should be intensified, at least in ICUs and in oncology and hematology specialties. Whether surveillance in ICUs also should cover infections that manifest in wards after patients have been discharged from ICUs requires further analysis. In conclusion, the overall rate of nosocomial BSIs in Finnish hospitals was similar to the rates reported for other European countries and for the United States. However, the proportions of BSIs caused by S. aureus, enterococci, and yeasts were smaller, and the prevalence of antibiotic susceptibility among S. aureus and enterococci was significantly higher. HOSPITAL INFECTION SURVEILLANCE TEAM MEMBERS Helsinki University Central Hospital: V. Valtonen, E. Kolho, V. J. Anttila, P. Carlson, A. Aalto, M. Hakanen, M. Jalkanen, T. Lappalainen, T. Salomaa, S. Taskinen, L. Tiittanen, E. Tenhunen, and I. Tötterman. Jorvi Hospital: A. Kostiala, A. Ruponen, and J. Nieminen. Päijät-Häme Central Hospital: H. Sarkkinen, A. Reiman, and I. Talvitie. Tampere University Hospital: J. Lumio, R. Vuento, and R. Levola. National Public Health Institute: O. Lyytikäinen, M. Ratia, M. Seger, T. Möttönen, J. Vuopio-Varkila, P. Huovinen, P. Ruutu, M. Vaara, and P. Leinikki. References 1. Horan TC, White JW, Jarvis WR, et al. Nosocomial infection surveillance. MMWR Morb Mortal Wkly Rep 1984; 35: Haley RW, Hooton TM, Culver DH, et al. Nosocomial infections in US hospitals, : estimated frequency by selected characteristics of patients. Am J Med 1981; 70: Haley RW, Culver DH, White JW, Morgan WM, Emori TG. The national nosocomial infection rate a new need for vital statistics. Am J Epidemiol 1985; 121: Sprengler RF, Greenough WB 3rd. Hospital costs and mortality attributed to nosocomial bacteremias. JAMA 1978; 240: Pittet D. Nosocomial bloodstream infections. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 3rd ed. Baltimore: Williams & Wilkins, 1997: Centers for Disease Control and Prevention. Increase in national hospital discharge surveys rates for septicemia United States. MMWR Morb Mortal Wkly Rep 1990; 39: Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, Am J Med 1991; 91(Suppl 3B):86S 9S. 8. Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group. Diagn Microbiol Infect Dis 1999; 33: Diekeman DJ, Pfaller MA, Jones RN, et al. Trends in antimicrobial e18 CID 2002:35 (15 July) Lyytikäinen et al.
6 susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents 2000; 13: Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and SENTRY Participants Group. Clin Infect Dis 2000; 30: Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121: Jarvis WR, Cookson ST, Robles MB. Prevention of nosocomial bloodstream infections: a national and international priority. Infect Control Hosp Epidemiol 1996; 17: Scheckler WE, Brimhall D, Buck AS, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Infect Control Hosp Epidemiol 1998; 19: Correa L, Pittet D. Problems and solutions in hospital-acquired bacteremia. J Hosp Infect 2000; 46: Centers for Disease Control and Prevention. Nosocomial infection rate for interhospital comparison: limitations and possible solutions. Infect Control Hosp Epidemiol 1991; 12: European Antibiotic Resistance Surveillance System. EARSS annual report Available at: Accessed on: 23 September Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, Am J Infect Control 1988; 16: Nosocomial Infection National Surveillance Scheme. Surveillance of hospital-acquired bacteraemia in English hospitals London, Available at: Accessed on: 23 July Edmond MB, Wallance SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997; 24: Nosocomial Bloodstream Infections in Finland CID 2002:35 (15 July) e19
Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More informationNosocomial Bloodstream Infections: Organisms, Risk Factors, and Implications
S139 Nosocomial Bloodstream Infections: Organisms, Risk Factors, and Implications Adolf W. Karchmer Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston,
More informationPrevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
University of Massachusetts Medical School escholarship@umms Open Access Articles Open Access Publications by UMMS Authors 5-10-2004 Prevalence and antimicrobial susceptibilities of bacteria isolated from
More informationOverview of Nosocomial Infections Caused by Gram-Negative Bacilli
HEALTHCARE EPIDEMIOLOGY Robert A. Weinstein, Section Editor INVITED ARTICLE Overview of Nosocomial Infections Caused by Gram-Negative Bacilli Robert Gaynes, Jonathan R. Edwards, and the National Nosocomial
More informationHospital Acquired Infections in the Era of Antimicrobial Resistance
Hospital Acquired Infections in the Era of Antimicrobial Resistance Datuk Dr Christopher KC Lee Infectious Diseases Unit Department of Medicine Sungai Buloh Hospital Patient Story 23 Year old female admitted
More informationNosocomial Infections: What Are the Unmet Needs
Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com
More informationEtiology of blood culture isolates among patients in a multidisciplinary teaching hospital in Kuala Lumpur
Etiology J Microbiol of blood Immunol culture Infect. isolates in a teaching hospital 2007;40:432-437 Etiology of blood culture isolates among patients in a multidisciplinary teaching hospital in Kuala
More informationOver the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.
Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years Ronald N. Jones, MD Multiple surveillance studies have demonstrated that resistance among prevalent pathogens is increasing
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationSUPPLEMENT ARTICLE. S114 CID 2001:32 (Suppl 2) Diekema et al.
SUPPLEMENT ARTICLE Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe,
More informationSummary of the latest data on antibiotic resistance in the European Union
Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationSURVEILLANCE AND INFECTION CONTROL IN AN INTENSIVE CARE UNIT
Vol. 26 No. 3 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 1 SURVEILLANCE AND INFECTION CONTROL IN AN INTENSIVE CARE UNIT Giovanni Battista Orsi, MD; Massimiliano Raponi, MD; Cristiana Franchi, MD; Monica
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationTITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline
Site: Saint Joseph Hospital - NICU Original Effective Date: 6/1/2016 Next Review Date: 6/1/2019 TITLE: Practice Guideline Purpose: Timely and appropriate treatment of late-onset sepsis with antibiotic
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationSource: Portland State University Population Research Center (
Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:
More informationDuring the second half of the 19th century many operations were developed after anesthesia
Continuing Education Column Surgical Site Infection and Surveillance Tae Jin Lim, MD Department of Surgery, Keimyung University College of Medicine E mail : tjlim@dsmc.or.kr J Korean Med Assoc 2007; 50(10):
More informationORIGINAL INVESTIGATION. Reemergence of Gram-negative Health Care Associated Bloodstream Infections
ORIGINAL INVESTIGATION Reemergence of Gram-negative Health Care Associated Bloodstream Infections Svenja J. Albrecht, MD; Neil O. Fishman, MD; Jennifer Kitchen, MD, PhD; Irving Nachamkin, DrPH, MPH; Warren
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More informationTaking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms
Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms Nimalie D. Stone, MD,MS Division of Healthcare Quality Promotion National
More informationLack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
Infect Dis Ther (2014) 3:55 59 DOI 10.1007/s40121-014-0028-8 BRIEF REPORT Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationBacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India
ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching
More informationAntibiotic Susceptibility Patterns of Community-Acquired Urinary Tract Infection Isolates from Female Patients on the US (Texas)- Mexico Border
Antibiotic Susceptibility Patterns of Community-Acquired Urinary Tract Infection Isolates from Female Patients on the US (Texas)- Mexico Border Yvonne Vasquez, MPH W. Lee Hand, MD Department of Research
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationMethicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives John Jernigan, MD, MS Alex Kallen, MD, MPH Division of Healthcare Quality Promotion Centers for Disease
More informationOverview of Infection Control and Prevention
Overview of Infection Control and Prevention Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry Green and Salah Gammouh
More informationRCH antibiotic susceptibility data
RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationSurveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,
Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at
More informationSurgical site infections: Assessing risk factors, outcomes and antimicrobial sensitivity patterns
African Journal of Microbiology Research Vol. 3 (4) pp. 175-179 April, 29 Available online http://www.academicjournals.org/ajmr ISSN 1996-88 29 Academic Journals Full Length Research Paper Surgical site
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationCipro for gram positive cocci in urine
Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More information1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection
Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationEach copy of any part of a JSTOR transmission must contain the same copyright notice that appears on the screen or printed page of such transmission.
Nosocomial and Community-Acquired Staphylococcus aureus Bacteremias from 1980 to 1993: Impact of Intravascular Devices and Methicillin Resistance Author(s): James P. Steinberg, Catherine C. Clark, Betsy
More informationMRSA in the United Kingdom status quo and future developments
MRSA in the United Kingdom status quo and future developments Dietrich Mack Chair of Medical Microbiology and Infectious Diseases The School of Medicine - University of Wales Swansea P R I F Y S G O L
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationHorizontal vs Vertical Infection Control Strategies
GUIDE TO INFECTION CONTROL IN THE HOSPITAL Chapter 14 Horizontal vs Vertical Infection Control Strategies Author Salma Abbas, MBBS Michael Stevens, MD, MPH Chapter Editor Shaheen Mehtar, MBBS. FRC Path,
More informationInfection Linelist. Infections Occurred Between 10/1/ :00:00 AM To 11/1/ :00:00 AM 2RCW2. Gastroenteritis (Adult) Urinary Tract
Infection Linelist Infections Occurred Between 10/1/2013 12:00:00 AM To 11/1/2013 12:00:00 AM 2RCW2 10/9/13 02407693 36890294 2094 1 32 M CLOSTRIDIUM DIFFICILE 10/26/13 99342791 37024716 2046 1 42 M CLOSTRIDIUM
More informationKonsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program
Konsequenzen für Bevölkerung und Gesundheitssysteme Stephan Harbarth Infection Control Program University of Geneva Hospitals Outline Introduction What data sources are available? AMR-associated outcomes
More informationGuidelines for Laboratory Verification of Performance of the FilmArray BCID System
Guidelines for Laboratory Verification of Performance of the FilmArray BCID System Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes quality standards for all laboratory
More informationEpidemiology and Microbiology of Surgical Wound Infections
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 918 922 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Epidemiology and Microbiology of Surgical
More informationQUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)
Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP),
More informationCanadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS FINAL November 29, 2017 Working Group: Joanne Langley (Chair),
More informationMDRO in LTCF: Forming Networks to Control the Problem
MDRO in LTCF: Forming Networks to Control the Problem Suzanne F. Bradley, M.D. Professor of Internal Medicine Division of Infectious Disease University of Michigan Medical School VA Ann Arbor Healthcare
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationAntimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals
MAJOR ARTICLE Antimicrobial Resistance Trends and Outbreak Frequency in United States Hospitals Daniel J. Diekema, 1,2 Bonnie J. BootsMiller, 1,2 Thomas E. Vaughn, 3 Robert F. Woolson, 3 Jon W. Yankey,
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationAntimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013
Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases
More informationInfection Control of Emerging Diseases
2016 EPS Training Event Martin E. Evans, MD Director, VHA MDRO Program National Infectious Diseases Service Lexington, KY & Cincinnati, OH Infection Control of Emerging Diseases 2016 EPS Training Event
More informationNorth West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families
Document Title and Reference : Guideline for the management of multi-drug resistant organisms (MDRO) Main Author (s) Simon Power Ratified by: GM NSG Date Ratified: February 2012 Review Date: March 2017
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationScreening programmes for Hospital Acquired Infections
Screening programmes for Hospital Acquired Infections European Diagnostic Manufacturers Association In Vitro Diagnostics Making a real difference in health & life quality June 2007 HAI Facts Every year,
More informationGram negative bacteraemia
Gram negative bacteraemia David Enoch Consultant Medical Microbiologist PHE Cambridge Cambridge University Hospitals NHS FT Overview Gram negative bacteraemia Changing epidemiology in England Epidemiology
More informationHealthcare-associated Infections and Antimicrobial Use Prevalence Survey
Healthcare-associated Infections and Antimicrobial Use Prevalence Survey Shamima Sharmin, M.B.B.S., MSc, MPH Emerging Infections Program New Mexico Department of Health Agenda Recognize healthcare-associated
More informationEmpiric antimicrobial use in the treatment of dialysis related infections in RIPAS Hospital
Original Article Brunei Int Med J. 2013; 9 (6): 372-377 Empiric antimicrobial use in the treatment of dialysis related infections in RIPAS Hospital Lah Kheng CHUA, Department of Pharmacy, RIPAS Hospital,
More informationActive Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.
Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationIncidence and antimicrobial resistance among potential nosocomial bacteria isolated from indoor environment of hospital
ISSN: 2319-7706 Volume 4 Number 3 (2015) pp. 134-142 http://www.ijcmas.com Original Research Article Incidence and antimicrobial resistance among potential nosocomial bacteria isolated from indoor environment
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationHand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY
Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY MDROs and Hand Hygiene Guidelines HH Apr14 The Science of Hand Hygiene in Healthcare Settings
More informationINFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER
INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationApproval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017
WRHA Infection Prevention and Control Program Operational Directives Admission Screening for Antibiotic Resistant Organisms (AROs): Methicillin Resistant Staphylococcus aureus (MRSA) and Vancomycin Resistant
More informationKey words: Urinary tract infection, Antibiotic resistance, E.coli.
Original article MICROBIOLOGICAL STUDY OF URINE ISOLATES IN OUT PATIENTS AND ITS RESISTANCE PATTERN AT A TERTIARY CARE HOSPITAL IN KANPUR. R.Sujatha 1,Deepak S 2, Nidhi P 3, Vaishali S 2, Dilshad K 2 1.
More informationCUMULATIVE ANTIBIOGRAM
BC Children s Hospital and BC Women s Hospital & Health Centre CUMULATIVE ANTIBIOGRAM 2017 Division of Medical Microbiology Department of Pathology and Laboratory Medicine Page 1 of 5 GRAM-POSITIVE BACTERIA
More informationNational Surveillance of Antimicrobial Resistance
National Surveillance of Antimicrobial Resistance Report to Ministry of Health by Sri Lanka College of Microbiologists SLCM ARSP & NLBSA Technical Committees December 2014 National Surveillance of Antimicrobial
More informationBacteriological Study of Catheter Associated Urinary Tract Infection in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 9 (2016) pp. 640-644 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.509.073
More informationBurden of disease of antibiotic resistance The example of MRSA. Eva Melander Clinical Microbiology, Lund University Hospital
Burden of disease of antibiotic resistance The example of MRSA Eva Melander Clinical Microbiology, Lund University Hospital Discovery of antibiotics Enormous medical gains Significantly reduced morbidity
More informationTreatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals
Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with
More informationMICHAEL A. PFALLER,* RONALD N. JONES, GARY V. DOERN, KARI KUGLER, AND THE SENTRY PARTICIPANTS GROUP
ANTIROBIAL AGENTS AND CHEMOTHERAPY, July 1998, p. 1762 1770 Vol. 42, No. 7 0066-4804/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Bacterial Pathogens Isolated from
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationExecutive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts
Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Investigational Team: Diane Brideau-Laughlin BSc(Pharm),
More informationPreventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier
More informationReceived 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationTrends in Bloodstream Infections at a Korean University Hospital between 2008 and 2013
Ann Clin Microbiol Vol. 18, No. 1, March, 2015 http://dx.doi.org/10.5145/acm.2015.18.1.14 pissn 2288-0585 eissn 2288-6850 Trends in Bloodstream Infections at a Korean University Hospital between 2008 and
More informationPost-operative surgical wound infection
Med. J. Malaysia Vol. 45 No. 4 December 1990 Post-operative surgical wound infection Yasmin Abu Hanifah, MBBS, MSc. (London) Lecturer Department of Medical Microbiology, Faculty of Medicine, University
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Enterococcal Species
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 44 Enterococcal Species Authors Jacob Pierce, MD, Michael Edmond, MD, MPH, MPA Michael P. Stevens, MD, MPH Chapter Editor Victor D. Rosenthal, MD, CIC,
More informationMeasurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist
Measurement of Antimicrobial Drug Use Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist Defined Daily Dose Target Audience: Administrators and Epidemiologists Standardized definition
More informationMeropenem for all? Midge Asogan ICU Fellow (also ID AT)
Meropenem for all? Midge Asogan ICU Fellow (also ID AT) Infections Common reason for presentation to ICU Community acquired - vs nosocomial - new infection acquired within hospital environment Treatment
More informationAntibiotic Usage and Microbial Resistance: Indian Scenario
Antibiotic Usage and Microbial Resistance: Indian Scenario Dr. Srinivas Murki, Consultant Neonatologist,Fernandez Hospital, Hyderabad, Andhra Pradesh-503001, India Email: srinivas_murki2001@yahoo.com Abstract
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More information